Global Search | Novartis United States of America

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 850 results

Media Release / Oct 26, 2023

Novartis confirms unconstrained supply for Pluvicto® and continues to significantly expand the number of treatment centers

US FDA has classified drug shortage status as resolved1Novartis capacity to produce Pluvicto will continue to grow with anticipated expansions to the manufacturing network in the US and globally…
Story / Sep 15, 2023

Know the Facts and Be an Advocate This Prostate Cancer Awareness Month

Education and Awareness

Novartis is sharing information and resources to empower people affected by prostate cancer during Prostate Cancer Awareness Month
Media Release / Jun 16, 2018

Novartis JULIET trial of Kymriah demonstrates more than one-year durability of responses in adults with relapsed or refractory DLBCL
Media Release / Jun 15, 2018

Novartis survey uncovers real-world impact of immune thrombocytopenia or ITP, a rare blood disease, on patients' quality of life
Media Release / Jun 03, 2018

Third Novartis Phase III trial shows Kisqali® combination therapy significantly improves PFS in HR+/HER2- advanced breast cancer
Media Release / May 30, 2018

FDA expedites review of Novartis drug Promacta® for first-line severe aplastic anemia (SAA)
Media Release / May 28, 2018

Patient-reported outcomes tool revealed significant improvement in symptom frequency and quality of life domains with Entresto®
Media Release / May 17, 2018

Novartis and Amgen announce FDA approval of Aimovig™ (erenumab-aooe), a novel treatment developed specifically for migraine prevention
Media Release / May 17, 2018

Novartis data at ASCO and EHA reinforce company's commitment to reimagining cancer
Media Release / May 17, 2018

Alcon teams up with Venus Williams, tennis champion and dry eye sufferer, to launch Systane® Complete eye drops

‹ Previous page
1
…
20
21
22
23
24
25
26
…
85
› Next page